Award
University of Kentucky 5F31HL175979-02
PPARgamma Coregulators in Rosiglitazone-Induced Cardiovascular Disease
Recipient
University of Kentucky
Award Amount
$36,094.00
Ceiling
$36,094.00
Awarded
January 31, 2026
Identifier
5F31HL175979-02
Research grant awarded to study PPARgamma coregulators in rosiglitazone-induced cardiovascular disease, focusing on molecular biology techniques to understand cardiac dysfunction mechanisms.
Description
A research grant opportunity from the National Heart Lung and Blood Institute (NHLBI) for a project on PPARĪ³ coregulators related to rosiglitazone-induced cardiovascular disease. The project involves advanced molecular biology techniques and aims to understand the mechanisms leading to cardiac dysfunction in obesity and high-fat diet contexts.